Over the past decade, the role of the 14–3-3 protein has received increasing interest. Seven
subtypes of 14–3-3 proteins exhibit high homology; however, each subtype maintains its …

Aims The concept of “atrial cardiomyopathy”(AtCM) had been percolating through the
literature since its first mention in 1972. Since then, publications using the term were …

Atrial fibrillation (AF) is a cardiac arrhythmia caused by electrophysiological anomalies in the
atrial tissue, tissue degradation, structural abnormalities, and comorbidities. A direct …

Purpose Diabetes mellitus is an independent risk factor for atrial fibrillation (AF), which may
be related to accumulation of advanced glycation end products (AGEs). However, the …

The utility of rodents for research related to atrial fibrillation (AF) is growing exponentially.
However, the obtained arrhythmic waveforms are often mixed with ventricular signals and …

Atrial fibrillation (AF) is a continually growing health-care burden that often presents together
with metabolic disorders, including diabetes mellitus and obesity. Current treatments often …

Atrial fibrillation (AF) is a cardiac disease characterized by disordered atrial electrical
activity. Atrial inflammation and fibrosis are involved in AF progression. Costunolide (COS) is …

Atrial fibrillation (AF) is a prevalent arrhythmia closely associated with atrial fibrosis, posing
significant challenges to cardiovascular health. Recent studies have identified the sodium …

The exact processes underlying atrial fibrillation (AF) are still unclear. It has been suggested
that epicardial adipose tissue (EAT) may contribute to arrhythmias and can release various …

Thrombin supports coagulation-independent inflammation via protease-activated receptors
(PAR). PAR4 is specifically increased in obese human atria, correlating with NLRP3 …